Diabetes complicated with sarcopenia
Conditions
Interventions
Control Group:Routine treatment and nursing (including: 1. maintaining original diabetes medication
2. nutritional intervention (daily protein =1.2g/kg)
3. health education
4. psychological care
5. telephone/WeChat follow-up after discharge)
Observation Group:Routine treatment and nursing + exercise program based on COM-B model (including: 1. exercise plan development and video demonstration
2. exercise diary recording
3. weekly telephone/monthly home visit supervision
4. caregiver training)
Sponsors
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for type 2 diabetes mellitus and sarcopenia; 2. Aged 60 years or older, with underlying diseases in a stable stage; 3. Conscious, with certain comprehension and mobility, and able to actively cooperate with researchers throughout the study; 4. Voluntarily participate in the study and sign the informed consent form, with the informed consent process in line with ethical requirements.
Exclusion criteria
Exclusion criteria: 1. Patients with comorbidities that may cause sarcopenia, including hyperthyroidism, malignant tumor, liver cirrhosis, and chronic kidney disease. 2. Those unable to cooperate in completing the tests. 3. Patients with severe organ failure or a history of malignant tumor. 4. Patients with cardiac pacemaker, cardiac stent, or other metal implants who are ineligible for body composition analyzer measurement. 5. Patients with diseases that impede limb movement, such as cerebral hemorrhage, cerebral infarction, fracture, moderate to severe edema, Parkinson’s disease, etc. 6. Patients with severe mental illness, psychological disorders, or cognitive impairment. 7. Patients who participated in other clinical trials within 1 month prior to this study or are currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal muscle mass (relative skeletal muscle index, limb and trunk skeletal muscle mass, waist-to-hip ratio); | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle strength (grip strength);Physical function (6-meter walk speed);Biochemical markers (fasting blood glucose, glycated hemoglobin, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol);Activities of Daily Living (ADL) score;Exercise Self-Efficacy Scale (ESES);Exercise adherence; | — |
Countries
China
Contacts
Public ContactFu Meiling
The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Outcome results
None listed